A woman with atypical hemolytic uremic syndrome (aHUS) successfully underwent a second kidney transplant as treatment with Soliris (eculizumab) largely prevented or eased the complications that led to failure of her first transplant. The medication has helped stabilize the woman’s kidney function for four years, researchers wrote in a…